T cell engineering with TCRs is a growing area of immuno-oncology with recent breakthroughs in clinical settings. The T-Cure approach involves identifying and isolating a high avidity TCR which specifically recognizes an intracellular or cell-surface target in solid tumors. This TCR is then typically introduced into a viral vector that can deliver the TCR into the patients’ own T cells in an ex vivo setting. After successful genetic modification of the T cells in this way, T cells are re-introduced into the patient, and render effective killing of tumor cells in vivo.

GrayWolf Sensing Solutions Downloads

Utilizing GrayWolf Meters to Measure for Asthma Triggers - Application Note

Contact supplier